Search
Technetium Tc-99m sulfur colloid
go.drugbank.com/drugs/DB09397Approveda radiopharmaceutical diagnostic agent used in the evaluation of various conditions including lymph node metastases in breast cancer, detection of shunt patency, imaging of reticuloendothelial cells for
Products: Kit for the Preparation of Technetium Tc 99m Sulfur Colloid, Kit for the Prepartion of Technetium Tc99m Sulfur ColloidLiraglutide
go.drugbank.com/drugs/DB06655ApprovedInvestigational[Label,A6932] Liraglutide is 97% similar to native human GLP-1, differing primarily by substituting arginine for lysine at position 34.
Mixtures: Xultophy 100 units/mL + 3.6 mg/mL Solution for InjectionProducts: solution for injection in pre-filled pen 6mg/ml, SOLUTION FOR INJECTION IN PRE-FILLED PEN 6MG/MLDacarbazine
go.drugbank.com/drugs/DB00851ApprovedInvestigationalDacarbazine with Oblimersen is in clinical trials for the treatment of malignant melanoma.
Products: DTI FOR INJECTION, Dacarbazine for Injection BPAtosiban
go.drugbank.com/drugs/DB09059ApprovedInvestigationalAtosiban is licensed in proprietary and generic forms for the delay of imminent pre-term birth in pregnant adult women.
Products: TRACTOCILE (7.5 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION), TRACTOCILE 7.5MG/ML CONCENTRATE FOR SOLUTION FOR INFUSIONAntihemophilic factor, human recombinant
go.drugbank.com/drugs/DB00025ApprovedInvestigationalHuman recombinant antihemophilic factor (AHF) or Factor VIII, 2332 residues, glycosylated, produced by CHO cells
Products: ADVATE 250 IU Powder and Solvent for Solution for Injection, ADVATE 500 IU Powder and Solvent for Solution for InjectionCoagulation factor VIIa Recombinant Human
go.drugbank.com/drugs/DB00036ApprovedInvestigationalRecombinant human coagulation Factor VIIa (rFVIIa), intended for promoting hemostasis by activating the extrinsic pathway of the coagulation cascade.
Products: powder and solvent for solution for injection 2mg, powder and solvent for solution for injection 1mgSomatrogon
go.drugbank.com/drugs/DB14960ApprovedInvestigational[A241515] Recombinant growth hormone therapy for growth hormone deficiency and other conditions has been available since 1985, with daily administration being the standard treatment for many years. … [L39060] In June 2023, the FDA approved the use of somatrogon also for the treatment of pediatric growth hormone deficiency.
Products: Ngenla 60mg/1.2mL Solution for Injection in Pre-filled Pen, Ngenla 24mg/1.2mL Solution for Injection in Pre-filled PenIsavuconazonium
go.drugbank.com/drugs/DB06636ApprovedInvestigationalThis formulation also avoids the use of a cyclodextrin vehicle for solubilization required for intravenous administration of other antifungals such as voriconazole and posaconazole, eliminating concerns … [A6913,A6914,A262706] On December 08, 2023, the FDA approved the expanded use of isovuconazonium in pediatric patients for the same indications.[L49251]
Products: CRESEMBA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 200MGNirsevimab
go.drugbank.com/drugs/DB16258ApprovedInvestigational[L44146] Nirsevimab was also approved by Health Canada on April 19, 2023 and by the FDA in July 17, 2023 for the same indication.[L46392,L47461] … [A254571,L44146] On November 2022, nirsevimab was approved by the EMA for the prevention of RSV lower respiratory tract disease in newborns and infants.
Categories: Antiinfectives for Systemic UseProducts: Beyfortus solution for injection in pre-filled syringe 50 mg/ 0.5 mL, Beyfortus solution for injection in pre-filled syringe 100 mg/ 1.0 mLFremanezumab
go.drugbank.com/drugs/DB14041ApprovedInvestigationalFremanezumab is a humanized monoclonal antibody targeted against human calcitonin gene-related peptide (CGRP) for the prevention of migraine headaches.
Products: AJOVY SOLUTION FOR INJECTION IN PRE-FILLED PEN 225 MG/1.5ML, AJOVY SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 225 MG/1.5ML